Showing results (111-120 of 292) with videos related to
Sort By:
Pageof 30
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 3, 2020
European Stakeholder Learnings Regarding Biosimilars: Part I-Improving Biosimilar Understanding and AdoptionLiese Barbier, Steven Simoens, Arnold G Vulto, et al.Applied Health Economics and Health Policy|August 3, 2016
Clinical, Economic and Policy Implications of Drug Shortages in the European UnionElfi De Weerdt, Steven Simoens, Minne Casteels, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 12, 2020
Shedding Light on Reimbursement Policies of Companion Diagnostics in European CountriesLaurenz Govaerts, Steven Simoens, Walter Van Dyck, et al.Frontiers in Pharmacology|November 19, 2015
Toward a European definition for a drug shortage: a qualitative studyElfi De Weerdt, Steven Simoens, Minne Casteels, et al.Frontiers in Pharmacology|December 3, 2021
A Comparative Analysis of Pricing and Reimbursement of Cystic Fibrosis Transmembrane Conductance Regulator Modulators in EuropeKhadidja Abdallah, Kris De Boeck, Marc Dooms, et al.Frontiers in Pharmacology|August 5, 2022
How Can We Optimize the Value Assessment and Appraisal of Orphan Drugs for Reimbursement Purposes? A Qualitative Interview Study Across European CountriesAlessandra Blonda, Yvonne Denier, Isabelle Huys, et al.Journal De Pharmacie De Belgique|February 27, 2010
[Orphan diseases and orphan medicines: a Belgian and European study]Alain Denis, Lut Mergaert, Christel Fostier, et al.The British Journal of General Practice : the Journal of the Royal College of General Practitioners|February 22, 2005
The effectiveness of community maintenance with methadone or buprenorphine for treating opiate dependenceSteven Simoens, Catriona Matheson, Christine Bond, et al.Current Medical Research and Opinion|January 31, 2008
A cost-effectiveness analysis of antimicrobial treatment of community-acquired pneumonia taking into account resistance in BelgiumMonique Martin, Lee Moore, Sibilia Quilici, et al.Journal of Medical Economics|May 21, 2010
Budget impact analysis of orphan drugs in Belgium: estimates from 2008 to 2013Alain Denis, Lut Mergaert, Christel Fostier, et al.Pageof 30